Matt, Mark, and Dylan talk to Heather Bresch, CEO of Mylan, about the EpiPen and drug prices. They also introduce a new segment called the Mark-et Summary, and bring you another round of the Salt & Pepper 500.
Matt, Mark, and Dylan talk to Heather Bresch, CEO of Mylan, about the EpiPen and drug prices. They also introduce a new segment called the Mark-et Summary, and bring you another round of the Salt & Pepper 500.